Methotrexate
Summary of product characteristics
Effective Time
20221031
Version
5
Spl Product Data Elements
Methotrexate Methotrexate METHOTREXATE METHOTREXATE ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE LACTOSE MONOHYDRATE MAGNESIUM STEARATE STARCH, CORN YELLOW ROUND L2
Application Number
ANDA207812
Brand Name
Methotrexate
Generic Name
Methotrexate
Product Ndc
70771-1058
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1058-1 Methotrexate tablets, USP 2.5 mg Rx only 36 tablets Methotrexate tablets, USP
910 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.